Efficacy and Tolerability of Peginterferon α-2a and Peginterferon α-2b, Both plus Ribavirin, for Chronic Hepatitis C: A Meta-Analysis of Randomized Controlled Trials
Figure 5
The relapse rate of CHC patients who received the two regimens.
(a) The overall relapse comparison
(b) The relapse rate of naïve CHC patients treated with the two types of peginterferons
(c) The relapse rate of CHC patients with HCV genotype 1 or 4 treated with the two types of peginterferons